It would be “disastrous” to market generic OxyContin without making it abuse-resistant, [Dr. Lynn] Webster says. “There should be no opioids on the market that don’t have some abuse-deterrent formulation.”
Why, Dr. Webster, could your opinion have been influenced by the drug study you’re conducting?
But about one-quarter of abusers say they’ve figured out how to defeat the deterrent, according to a 2012 article in the New England Journal of Medicine.
“A pill that’s harder to snort or inject isn’t necessarily less addictive,” says Andrew Kolodny, head of psychiatry at Maimonides Medical Center in New York, who studies policy on opioid drugs. People also get addicted by swallowing pills, he notes.
“One of my concerns is that this new rule could set up an arms race for the pharmaceutical companies to create abuse-deterrent versions because they have patent protection,” Kolodny told Shots. “You’ll see marketing to prescribers that these pills are less addictive. That could potentially make things worse.”
An arms race? Seriously?
Definition of “arms race”: a competition between nations for superiority in the development and accumulation of weapons, especially between the US and the former Soviet Union during the Cold War.
Mr. Kolodny is now comparing drugs to military weapons? I swear, this guy is never happy. But he’s very good at setting up excuses for why things are getting “worse.”
Hey, Kolodny, whatcha gonna do when the DEA starts restricting your treatment drugs of choice? One which happens to have the abuse deterrent that you’re complaining about? First, they came for oxycodone, then hydrocodone, then…